D. Stroncek

D. Stroncek, K. Frank, Virginia Guptill, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Edward Abraham, Pearl Toy, A. Nathens, 2005, Critical care medicine.

Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantation.

S. Pittaluga, M. Sabatino, D. Kleiner, 2015, Blood.

Effect of storage levels of nitric oxide derivatives in blood components

A. Schechter, D. Stroncek, B. Piknova, 2012, F1000Research.

Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.

S. Hoffman, A. Magill, D. Stroncek, 2002, The American journal of tropical medicine and hygiene.

Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR)

S. Mocellin, D. Stroncek, D. Nagorsen, 2003, Journal of Translational Medicine.

Link between Interleukin-23 and Anti-CD4 Autoantibody Production in Antiretroviral-Treated HIV-Infected Individuals

Min Li, D. Stroncek, Fuli Mi, 2021, Journal of Virology.

Sporadic leukoreduction filter failure during red blood cell component preparation: beware of rapid filtration

D. Stroncek, H. Klein, S. Leitman, 2008, Transfusion.

Pasteurella multocida bacteremia in asymptomatic plateletpheresis donors: a tale of two cats

D. Stroncek, S. Leitman, B. J. Bryant, 2007, Transfusion.

Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6th-7 th2010"

M. Hendrix, K. Flaherty, P. Ascierto, 2011, Journal of Translational Medicine.

Emerging concepts in biomarker discovery; The US-Japan workshop on immunological molecular markers in oncology

E. Petricoin, L. Liotta, F. Marincola, 2009, Journal of Translational Medicine.

Heavy breathing in the blood bank: is it transfusion‐related acute lung injury, our anxiety, or both?

D. Stroncek, H. Klein, H. Klein, 2007, Transfusion.

Pulmonary transfusion reactions.

D. Stroncek, 2007, Seminars in hematology.

The value of pH as a quality control indicator for apheresis platelets

D. Stroncek, S. Leitman, J. Oblitas, 2005, Transfusion.

Treatment of normal individuals with granulocyte‐colony‐stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells

D. Stroncek, D. Stroncek, J. McCullough, 1996, Transfusion.

Allogeneic blood stem cell transplantation: considerations for donors.

N. Schmitz, A. Gratwohl, D. Stroncek, 1997, Blood.

Streptococcus agalactiae sepsis after transfusion of a plateletpheresis concentrate: benefit of donor evaluation

W. T. Stevens, D. Stroncek, S. Leitman, 2006, Transfusion.

Frequencies of SLC44A2 alleles encoding human neutrophil antigen‐3 variants in the African American population

D. Stroncek, W. Flegel, Pirmin Schmid, 2012, Transfusion.

Manufacturing Differences Affect Human Bone Marrow Stromal Cell Characteristics and Function: Comparison of Production Methods and Products from Multiple Centers

G. Shaw, D. Stroncek, J. Reems, 2017, Scientific Reports.

Hematopoietic growth factors—use in normal blood and stem cell donors: clinical and ethical issues

J. Adamson, D. Stroncek, B. Hirsch, 2008, Transfusion.

Platelet transfusions

P. Rebulla, D. Stroncek, 2007, The Lancet.

Persistence of recipient plasma cells and anti‐donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non‐myeloablative haematopoietic cell transplantation

J. P. McCoy, R. Srinivasan, J. McCoy, 2005, British journal of haematology.

Complement activation and neutropenia occurring during cardiopulmonary bypass.

D. Stroncek, C. Lammi-Keefe, D. Nicoloff, 1981, The Journal of thoracic and cardiovascular surgery.

Cellular Engineering

D. Stroncek, D. McKenna, 2021, Transfusion Medicine.

Variations in the expression of granulocyte antigen NB1

D. Stroncek, J. Procter, K. Matsuo, 2000, Transfusion.

CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial.

S. Steinberg, M. Stetler-Stevenson, D. Stroncek, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A. Dalmasso, D. Stroncek, J. McCullough, 1990, Transfusion.

Cell therapies for trauma and critical care medicine: critical issues in translation for cellular and novel therapies in trauma and critical care

D. Stroncek, D. McKenna, A. Mathew, 2019, Transfusion.

Optimal Storage Conditions for Apheresis Research (OSCAR): a Biomedical Excellence for Safer Transfusion (BEST) Collaborative study

D. Stroncek, T. Gniadek, D. McKenna, 2018, Transfusion.

Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy.

C. Klebanoff, D. Stroncek, M. Kruhlak, 2017, JCI insight.

Scaling up and scaling out: Advances and challenges in manufacturing engineered T cell therapies

D. Stroncek, S. Highfill, Hannah W Song, 2022, International reviews of immunology.

Overcoming Challenges in Process Development of Cellular Therapies

D. Stroncek, S. Highfill, 2019, Current Hematologic Malignancy Reports.

Autologous lymphapheresis for the production of chimeric antigen receptor T cells

D. Stroncek, T. Fry, C. Mackall, 2017, Transfusion.

Novel DNA-based T-Cell Activator Promotes Rapid T-Cell Activation and Expansion

D. Stroncek, E. Loghin, S. Highfill, 2020, Journal of immunotherapy.

Production of Clinical T Cell Therapies

M. Sabatino, D. Stroncek, V. Fellowes, 2015 .

Leukemia cells induce changes in human bone marrow stromal cells

F. Marincola, M. Sabatino, D. Stroncek, 2013, Journal of Translational Medicine.

CAR T-Cell: Cell Processing Laboratory Considerations

D. Stroncek, P. Jin, S. Highfill, 2020 .

Group O plasma as a media supplement for CAR‐T cells and other adoptive T‐cell therapies

D. Stroncek, W. Flegel, P. Jin, 2020, Transfusion.

Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.

Fumito Ito, Benjamin L. Kidder, Chengyu Liu, 2018, Cell reports.

Safeguarding the long-term health of hematopoietic stem cell donors: a continuous and evolving process to maintain donor safety and trust

D. Stroncek, J. McCullough, 2012, Expert review of hematology.

T cells and IFN-γ. These findings demonstrate that BACH2 is a key component of the molecular program of tumor immunosuppression and identify therapeutic targets for the reversal of immunosuppression in cancer. The transcription factor BACH2 promotes tumor immunosuppression

F. Marincola, K. Okkenhaug, Jenny H. Pan, 2016 .

The transcription factor BACH2 promotes tumor immunosuppression.

F. Marincola, K. Okkenhaug, Jenny H. Pan, 2016, The Journal of clinical investigation.

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer

D. Stroncek, J. Chung, H. Chung, 2009, Journal of Translational Medicine.

Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177

D. Stroncek, 2007, Current opinion in hematology.

Recent advances in the bcr-abl negative chronic myeloproliferative diseases

D. Stroncek, M. Bennett, 2006, Journal of Translational Medicine.

Factors influencing the availability of umbilical cord blood for banking and transplantation

D. Stroncek, J. McCullough, M. Clay, 1998, Transfusion.

Detection of granulocyte antibodies by flow cytometry without the use of pure granulocyte isolates

D. Stroncek, J. Procter, K. Matsuo, 2001, Immunohematology.

Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases

S. Kleinman, T. Simon, D. Stroncek, 2000 .

F. Marincola, P. Ascierto, D. Bedognetti, 2014, Molecular oncology.

F. Marincola, P. Ascierto, D. Bedognetti, 2014, Journal of Translational Medicine.

TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer

S. Steinberg, I. Pastan, J. Berzofsky, 2016, Oncoimmunology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control

D. Stroncek, Yihua Cai, P. Jin, 2021, Journal of translational medicine.

Characterization of a New Alloantigen (SH) on the Human Neutrophil Fcγreceptor IIIb

P. Bierling, D. Stroncek, P. Fromont, 1997 .

Variations in genes encoding neutrophil antigens NA1 and NA2

D. Stroncek, J. Procter, K. Matsuo, 2000, Transfusion.

In vitro RBC exposure to Plasmodium falciparum has no effect on RBC antigen expression

D. R. Chambers, A. Magill, D. Stroncek, 2002, Transfusion medicine.

At the end of the beginning: immunotherapies as living drugs

C. Peck, D. Stroncek, E. Feigal, 2019, Nature Immunology.

Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules

D. Stroncek, S. Feldman, Christian S. Hinrichs, 2018, Journal of Translational Medicine.

Effect of Cryopreservation on Autologous Chimeric Antigen Receptor T Cell Characteristics.

P. Dagur, D. Stroncek, T. Fry, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use

K. Zoon, D. Stroncek, C. Annunziata, 2019, Journal of Translational Medicine.

Dendritic cells: an immunotherapy coming of age.

D. Stroncek, F. M. Marincola, 2012, Immunotherapy.

Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products

D. Stroncek, H. Lei, Yihua Cai, 2020, Journal of Translational Medicine.

Blood Research: hematology and beyond

D. Stroncek, 2013, Blood research.

The establishment of a bank of stored clinical bone marrow stromal cell products

M. Sabatino, D. Stroncek, H. Klein, 2012, Journal of Translational Medicine.

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5th–6 th2011”

A. Hauschild, K. Flaherty, P. Ascierto, 2012, Journal of Translational Medicine.

Improving CAR T cell therapy by optimizing critical quality attributes.

Opal L. Reddy, D. Stroncek, S. Panch, 2020, Seminars in hematology.

Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.

K. Keyvanfar, P. Hanley, A. Barrett, 2015, Cytotherapy.

Turning laboratory findings into therapy: a marathon goal that has to be reached.

F. Marincola, D. Stroncek, B. Kotlán, 2009, Polskie Archiwum Medycyny Wewnetrznej.

The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective study

A. Paterson, D. Stroncek, C. Silliman, 1997, Transfusion.

Cytotoxic Activity Monocytes to Dendritic Cells but Lacks 15 kDa Granulysin Causes Differentiation of

V. Barr, A. Krensky, D. Stroncek, 2012 .

Helper B Cells Promote Cytotoxic T Cell Survival and Proliferation Independently of Antigen Presentation through CD27/CD70 Interactions1

F. Marincola, E. Wang, D. Stroncek, 2008, The Journal of Immunology.

Cancer vaccine strategies: translation from mice to human clinical trials

I. Pastan, J. Berzofsky, J. Trepel, 2018, Cancer Immunology, Immunotherapy.

Multicenter evaluation of the IL‐3‐pSTAT5 assay to assess the potency of cryopreserved stem cells from cord blood units: The BEST Collaborative study

D. Stroncek, J. Reems, N. Pineault, 2022, Transfusion.

LIN28A Expression Reduces Sickling of Cultured Human Erythrocytes

Y. T. Lee, Jeffery L. Miller, R. Braylan, 2014, PloS one.

Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactions.

S. Adams, D. Stroncek, E. Fadeyi, 2007, Transfusion medicine reviews.

GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8+ T cells

F. Marincola, E. Wang, D. Stroncek, 2008, Journal of Translational Medicine.

Antitumor vaccines, immunotherapy and the immunological constant of rejection.

F. Marincola, M. Sabatino, E. Wang, 2009, IDrugs : the investigational drugs journal.

INTRAMYOCARDIAL BONE MARROW STEM CELLS IN PATIENTS UNDERGOING CARDIAC SURGICAL REVASCULARIZATION.

A. Arai, D. Stroncek, V. Sachdev, 2020, Annals of Thoracic Surgery.

Global Transcriptional Analysis for Biomarker Discovery and Validation in Cancer and Hematological Malignancy Biologic Therapies

E. Wang, D. Stroncek, P. Jin, 2010 .

Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.

D. Stroncek, P. Keshaviah, D. Hammerschmidt, 1984, The Journal of laboratory and clinical medicine.

Transient spleen enlargement in peripheral blood progenitor cell donors given G-CSF

D. Stroncek, S. Leitman, T. Shawker, 2004, Journal of Translational Medicine.

G‐CSF‐induced spleen size changes in peripheral blood progenitor cell donors

D. Follmann, D. Stroncek, S. Leitman, 2003, Transfusion.

Effects of granulocyte–colony‐stimulating factor on potential normal granulocyte donors

D. Stroncek, J. McCullough, M. Clay, 1999, Transfusion.

Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy.

D. Stroncek, B. Savani, S. Panch, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Frequency of Human Leukocyte Antigen-A 24 Alleles in Patients With Melanoma Determined by Human Leukocyte Antigen-A Sequence-Based Typing

F. Marincola, D. Stroncek, M. Bettinotti, 2000, Journal of immunotherapy.

Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes.

D. Stroncek, Xiangdong Liu, I. Sereti, 2019, JCI insight.

Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome

D. Stroncek, S. Straus, J. Procter, 2003, Vox sanguinis.

Autoimmune Lymphoproliferative Syndrome: An Inherited Disorder with a High Incidence of Autoimmune Cytopenias

D. Stroncek, S. Straus, J. Dale, 2003, Transfusion Medicine and Hemotherapy.

RBC autoantibodies in autoimmune lymphoproliferative syndrome

D. Stroncek, S. Straus, J. Procter, 2001, Transfusion.

Improved gene transfer and normalized enzyme levels in primitive hematopoietic progenitors from patients with mucopolysaccharidosis type I using a bioreactor

D. Stroncek, C. Whitley, D. Pan, 2004, The journal of gene medicine.

Inhibition of adjuvant-induced TAM receptors potentiates cancer vaccine immunogenicity and therapeutic efficacy.

J. Berzofsky, D. Stroncek, J. Lasarte, 2020, Cancer letters.

Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.

James M. Harris, L. Zon, M. Dovey, 2011, Cell stem cell.

Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells.

M. Sabatino, D. Stroncek, P. Jin, 2013, Cytotherapy.

Administration of G–CSF plus dexamethasone producesgreater granulocyte concentrate yields while causing nomore donor toxicity than G–CSF alone

D. Stroncek, S. Leitman, J. Oblitas, 2001, Transfusion.

Changes in blood counts after the administration of granulocyte‐colony‐ stimulating factor and the collection of peripheral blood stem cells from healthy donors

D. Stroncek, D. Stroncek, J. McCullough, 1996, Transfusion.

Self-organized yolk sac-like organoids allow for scalable generation of multipotent hematopoietic progenitor cells from induced pluripotent stem cells

D. Goldstein, M. Kimura, T. Takebe, 2021, bioRxiv.

The gene overexpressed in polycythemia rubra vera, PRV‐1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31

D. Arthur, D. Stroncek, M. Bettinotti, 2006, Transfusion.

Expression of human neutrophil antigen‐2a (NB1) is increased in pregnancy

D. Stroncek, M. Bettinotti, K. Matsuo, 2003, Transfusion.

Analysis of the expression of NB1 antigen using two monoclonal antibodies

D. Stroncek, R. Shankar, L. Clement, 1996, Transfusion.

Neutrophil-specific antigen NB1 inhibits neutrophil-endothelial cell interactions.

D. Stroncek, G. Herr, L. B. Plachta, 1994, The Journal of laboratory and clinical medicine.

Biochemical characterization of the neutrophil-specific antigen NB1.

D. Stroncek, J. McCullough, K. Skubitz, 1990, Blood.

MHC-peptide specificity and T-cell epitope mapping: where immunotherapy starts.

F. Marincola, S. Mocellin, D. Stroncek, 2006, Trends in molecular medicine.

Laser Scanning Cytometry Evaluation of MART-1, gp100, and HLA-A2 Expression in Melanoma Metastases

F. Marincola, S. Rosenberg, S. Mocellin, 2001, Journal of immunotherapy.

Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases

D. Stroncek, Yihua Cai, R. Somerville, 2022, Journal of translational medicine.

Direct T cell–tumour interaction triggers TH1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme

F. Marincola, D. Bedognetti, M. Sabatino, 2014, British Journal of Cancer.

Migration deficit in monocyte-macrophages in human ovarian cancer

F. Marincola, E. Wang, D. Stroncek, 2008, Cancer Immunology, Immunotherapy.

Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function.

F. Prósper, C. Verfaillie, D. Stroncek, 1998, The Journal of clinical investigation.

Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor.

F. Prósper, C. Verfaillie, D. Stroncek, 1996, Blood.

Transfusion support for matched sibling allogeneic hematopoietic stem cell transplantation (1993–2010): factors that predict intensity and time to transfusion independence

A. Barrett, D. Stroncek, J. Tisdale, 2018, Transfusion.

The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils

D. Stroncek, R. Shankar, K. Skubitz, 2005, Journal of Translational Medicine.

Human Mesenchymal Stromal Cell (MSC) Characteristics Vary Among Laboratories When Manufactured From the Same Source Material: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

D. Stroncek, J. Reems, M. Fontaine, 2020, Frontiers in Cell and Developmental Biology.

CD4/CD8 T-Cell Selection Enhances CD22 CAR-T Cell Transduction and in-Vivo CAR-T Expansion: Updated Results on Phase I Anti-CD22 CAR Dose Expansion Cohort

D. Stroncek, T. Fry, Jiaqiang Ren, 2017 .

Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation

S. Rosenberg, M. Stetler-Stevenson, D. Stroncek, 2016 .

Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identification

S. Adams, D. Stroncek, F. Robbins, 2004, Journal of Translational Medicine.

High Throughput Hla Sequence-Based Typing (Sbt) Utilizing the Abi Prism® 3700 Dna Analyzer

F. Marincola, S. Adams, D. Stroncek, 2001, Tumori.

Gene expression profiling of cutaneous wound healing

F. Marincola, E. Wang, D. Stroncek, 2007 .

Hot on the trail of TRALI

D. Stroncek, 2006 .

CD177 polymorphisms: correlation between high‐frequency single nucleotide polymorphisms and neutrophil surface protein expression

D. Stroncek, M. Bettinotti, K. Walkovich, 2004, Transfusion.

Neutrophil‐Specific Antigen HNA‐2a (NB1, CD177): Serology, Biochemistry, and Molecular Biology

D. Stroncek, 2002, Vox sanguinis.

Neutrophil‐Specific Antigen NB1 Is Anchored Via a Glycosyl‐Phosphatidylinositol Linkage

Bo Sun, D. Stroncek, K. Skubitz, 1991, Journal of leukocyte biology.

Neutrophil Oxidants Inactivate Alpha4 ‐Protease Inhibitor and Promote PMN‐Mediated Detachment of Cultured Endothelium: Protection by Free Methionine

D. Stroncek, G. Vercellotti, P. Huh, 1986, Arteriosclerosis.

Primitive long-term culture initiating cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow.

F. Prósper, C. Verfaillie, D. Stroncek, 1997, Blood.

Prostaglandin E 2 enhances engraftment of human cord blood stem cells and shows long-term safety in preclinical non-human primate transplant models

James M. Harris, L. Zon, M. Dovey, 2017 .

RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management.

F. Marincola, A. Monaco, D. Stroncek, 2010, Blood.

Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO Typings.

J. Sperry, E. Angelantonio, Jasmine Schwartz, 2019, Anesthesiology.

Policies and procedures for the establishment of an allogeneic blood stem cell collection programme

D. Stroncek, J. McCullough, J. McCullough, 1997, Transfusion medicine.

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment

Simon C Watkins, T. Denning, D. Stroncek, 2017, Oncoimmunology.

Comparison of endometrial regenerative cells and bone marrow stromal cells

M. Sabatino, D. Stroncek, T. Ichim, 2012, Journal of Translational Medicine.

How do I structure logistic processes in preparation for outsourcing of cellular therapy manufacturing?

D. Stroncek, S. Panch, K. West, 2019, Transfusion.

Comparative analyses of industrial‐scale human platelet lysate preparations

D. Stroncek, J. Reems, P. Jin, 2017, Transfusion.

Neutropenia in a patient receiving intravenous immune globulin

D. Stroncek, L. Morton, R. Leshner, 1996, Journal of Neuroimmunology.

Changes in serum osteocalcin and bone‐specific alkaline phosphatase are associated with bone pain in donors receiving granulocyte–colony‐stimulating factor for peripheral blood stem and progenitor cell collection

D. Stroncek, J. McCullough, U. Garg, 1999, Transfusion.

Clinical Applications of Activated Immune Cells

F. Marincola, M. Sabatino, D. Stroncek, 2011 .

The chemical and immunoglobulin structural features necessary for reactions of quinine‐dependent antibodies to neutrophils

D. Stroncek, D. Stroncek, G. Herr, 1995, Transfusion.

Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis

D. Stroncek, G. Vercellotti, H. Jacob, 1992 .

Characterization of multiple quinine-dependent antibodies in a patient with episodic hemolytic uremic syndrome and immune agranulocytosis.

D. Stroncek, G. Vercellotti, H. Jacob, 1992, Blood.

Variations in novel cellular therapy products manufacturing.

D. Stroncek, J. Reems, M. Fontaine, 2020, Cytotherapy.

Cellular Engineering

D. Stroncek, D. McKenna, 2021, Transfusion Medicine.

Interagency Genome Amplification Testing Task Force: preliminary report

Toby Simon, I. Hewlett, D. Stroncek, 1998, Transfusion.

Granulocyte transfusions in the management of invasive fungal infections

Sameer S. Kadri, D. Stroncek, J. Gea-Banacloche, 2017, British journal of haematology.

Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies

S. Rutella, D. Stroncek, P. Filippini, 2015, Journal of Translational Medicine.

Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils

D. Stroncek, S. Leitman, B. J. Bryant, 2010, Transfusion.

Kinetics of G–CSF‐induced granulocyte mobilization in healthy subjects: effects of route of administration and addition of dexamethasone

D. Follmann, D. Stroncek, S. Leitman, 2002, Transfusion.

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

F. Marincola, P. Ascierto, D. Bedognetti, 2011, BMC Cancer.

Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.

A. Barrett, D. Stroncek, R. Childs, 2001, Blood.

Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies

M. Sabatino, D. Stroncek, V. Fellowes, 2014, Journal of Translational Medicine.

Assessment of the relative number of copies of the gene encoding human neutrophil antigen-2a (HNA-2a), CD177, and a homologous pseudogene by quantitative real-time PCR

D. Stroncek, K. Dittmar, M. Bettinotti, 2003, Immunohematology.

Concentration of citrate anticoagulant in peripheral blood progenitor cell collections

D. Stroncek, D. Stroncek, S. Burger, 1996, Transfusion.

Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products

D. Stroncek, Yihua Cai, J. Kochenderfer, 2022, Journal of Translational Medicine.

Composition of peripheral blood progenitor cell components collected from healthy donors

D. Stroncek, D. Stroncek, J. McCullough, 1997, Transfusion.

Immunoblotting characterization of neutrophil antigenic targets in autoimmune neutropenia.

D. Stroncek, R. Johnson, T. Kickler, 1989, Blood.

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor.

Thomas E. Hughes, S. Tsai, D. Stroncek, 2020, Haematologica.

Safe and efficient peripheral blood stem cell collection in patients with sickle cell disease using plerixafor

Thomas E. Hughes, S. Tsai, M. Weiss, 2019, Haematologica.

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL

D. Dimitrov, M. Sabatino, R. Orentas, 2017, Nature medicine.

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

J. Szer, D. Stroncek, J. Liesveld, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Red blood cells, transfusion‐related acute lung injury, and lipids: a role for liporeduction?

D. Stroncek, H. Klein, 2011, Transfusion.

Screening plateletpheresis donors for HLA antibodies on two high‐throughput platforms and correlation with recipient outcome

S. Adams, D. Stroncek, H. Klein, 2011, Transfusion.

Neutrophil alloantigens.

D. Stroncek, 2002, Transfusion medicine reviews.

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors

Opal L. Reddy, P. Danaher, D. Stroncek, 2022, Journal of translational medicine.

In vitro variables of red blood cell components collected by apheresis and frozen 6 and 14 days after collection

D. Stroncek, F. Rentas, K. Byrne, 2006, Transfusion.

Storage of G–CSF‐mobilized granulocyte concentrates

D. Stroncek, S. Leitman, T. Lightfoot, 2000, Transfusion.

Expression of neutrophil antigens after 10 days of granulocyte‐colony‐stimulating factor

D. Stroncek, D. Stroncek, J. McCullough, 1998, Transfusion.

The kinetics of G‐CSF mobilization of CD34+ cells in healthy people

D. Stroncek, D. Stroncek, J. McCullough, 1997, Transfusion medicine.

Expression of CD14, IL-10 and tolerogenic signature in dendritic cells inversely correlate with clinical and immunological response to TARP vaccination in prostate cancer patients

J. Berzofsky, M. Sabatino, D. Stroncek, 2016 .

A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies

S. Adams, D. Stroncek, H. Klein, 2008, Vox sanguinis.

The transfusion of neutrophil‐specific antibodies causes leukopenia and a broad spectrum of pulmonary reactions

D. Stroncek, H. Klein, S. Leitman, 2007, Transfusion.

Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease.

Thomas E. Hughes, S. Tsai, M. Weiss, 2021, Blood advances.

Quinine-dependent antibodies to neutrophils react with a 60-Kd glycoprotein on which neutrophil-specific antigen NB1 is located and an 85-Kd glycosyl-phosphatidylinositol-linked N-glycosylated plasma membrane glycoprotein.

D. Stroncek, R. Shankar, G. Herr, 1993, Blood.

Evaluation of solutions for the storage of granulocyte colony‐stimulating factor‐mobilized granulocyte concentrates

D. Stroncek, J. Gallelli, S. Leitman, 2001, Vox sanguinis.

Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell Donations.

D. Stroncek, B. Shaw, G. Switzer, 2021, Transplantation and cellular therapy.

Mobilized PBPC concentrates: a maturing blood component

D. Stroncek, P. Anderlini, D. Stroncek, 2001, Transfusion.

Molecular immune signatures of HIV‐1 vaccines in human PBMCs

F. Marincola, M. Sabatino, F. Buonaguro, 2009, FEBS letters.

The expression of NA antigens in people withunusual Fcγ receptor III genotypes

D. Stroncek, J. Procter, K. Matsuo, 2001, Transfusion.

HLAMatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients.

F. Marincola, S. Adams, D. Stroncek, 2006, Blood.

Transfusion Medicine 2 Platelet transfusions

Paolo Rebulla, P. Rebulla, D. Stroncek, 2007 .

Sodium morrhuate stimulates granulocytes and damages erythrocytes and endothelial cells: probable mechanism of an adverse reaction during sclerotherapy.

D. Stroncek, G. Vercellotti, H. Jacob, 1985, The Journal of laboratory and clinical medicine.

Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States.

D. Stroncek, M. Pulsipher, S. Leitman, 2010, Blood.

Protecting the health and safety of cell and tissue donors

D. Stroncek, L. England, 2015, ISBT science series.

Biotinylation modifies red cell antigens

J. Miller, Jeffery L. Miller, D. Stroncek, 1999, Transfusion.

Drug-induced immune neutropenia.

D. Stroncek, 1993, Transfusion medicine reviews.

Neonatal Immune Neutropenia Following the Administration of Intravenous Immune Globulin

S. Bertolone, D. Stroncek, H. Lassiter, 1993, The American journal of pediatric hematology/oncology.

Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.

F. Marincola, D. Stroncek, B. Kotlán, 2009, Immunotherapy.

Alloimmunization after granulocyte transfusions

D. Stroncek, S. Leitman, J. Gallin, 1996, Transfusion.

Retroviral transduction of peripheral blood leukocytes in a hollow‐ fiber bioreactor

D. Stroncek, C. Whitley, D. Stroncek, 1997, Transfusion.

A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities

F. Marincola, D. Stroncek, L. Bracci, 2009, Journal of cellular and molecular medicine.

Identification of Immune Dominant Cytomegalovirus Epitopes Using Quantitative Real-Time Polymerase Chain Reactions to Measure Interferon-&ggr; Production by Peptide-Stimulated Peripheral Blood Mononuclear Cells

F. Marincola, S. Mocellin, D. Stroncek, 2002, Journal of immunotherapy.

Identification of HLA-A*2402-restricted HCMV immediate early-1 (IE-1) epitopes as targets for CD8+ HCMV-specific cytotoxic T lymphocytes

D. Stroncek, S. Jeong, Kyungwon Lee, 2009, Journal of Translational Medicine.

Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansion

F. Marincola, D. Stroncek, M. Panelli, 2006, Journal of Translational Medicine.

Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non‐mobilized donor T cells for refractory severe aplastic anaemia

N. Young, D. Stroncek, R. Childs, 2017, British journal of haematology.

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma

S. Rosenberg, P. Youkharibache, D. Stroncek, 2019, Nature Medicine.

Current practices and prospects for standardization of the hematopoietic colony-forming unit assay: a report by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.

John McMannis, David McKenna, Hermann Eichler, 2013, Cytotherapy.

The establishment of a bank of stored clinical bone marrow stromal cell products

M. Sabatino, D. Stroncek, H. Klein, 2012, Journal of Translational Medicine.

Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.

M. Sabatino, D. Stroncek, H. Klein, 2011, Cytotherapy.

Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming

Ping Jin, Florina Moldovan, Francesco M. Marincola, 2016, Oncotarget.

Stem cells in melanoma development.

F. Marincola, M. Sabatino, E. Wang, 2009, Cancer letters.

Effects of starting cellular material composition on chimeric antigen receptor T‐cell expansion and characteristics

D. Stroncek, J. Kochenderfer, P. Jin, 2019, Transfusion.

Simplified process for the production of anti-CD19-CAR-engineered T cells.

Crystal Mackall, Marianna Sabatino, M. Sabatino, 2013, Cytotherapy.

Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment

Marianna Sabatino, S. Rosenberg, M. Sabatino, 2012, Journal of immunotherapy.

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.

Michael L. Wang, M. Stetler-Stevenson, D. Stroncek, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers

J. Lack, D. Stroncek, W. Faquin, 2021, Nature Medicine.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014

Martin F. Mihm, B. Schilling, F. Marincola, 2013, Journal of Translational Medicine.

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”

F. Marincola, J. Taube, G. Botti, 2013, Journal of Translational Medicine.

Adoptive Transfer of Escalating Doses of Ex Vivo Expanded Autologous Natural Killer (NK) Cells In Patients with Advanced Malignancies Following Bortezomib Treatment to Sensitize to NK-TRAIL Cytotoxicity

K. Keyvanfar, D. Stroncek, M. Berg, 2010 .

Robust Antitumor Activity and Low Cytokine Production by Novel Humanized Anti-CD19 CAR T Cells

D. Stroncek, T. Fry, A. Kizhakeyil, 2021, Molecular Cancer Therapeutics.

Comparison of DATs using traditional tube agglutination to gel column and affinity column procedures

D. Stroncek, J. Njoroge, J. Procter, 2001, Transfusion.

Main roads to melanoma

P. Ascierto, G. Palmieri, D. Stroncek, 2009, Journal of Translational Medicine.

Phase I Clinical Trial of an Autologous Dendritic Cell Vaccine Against HER2 Shows Safety and Preliminary Clinical Efficacy

S. Steinberg, J. Berzofsky, L. Weiner, 2021, Frontiers in Oncology.

Potency analysis of cellular therapies: the role of molecular assays

F. Marincola, M. Sabatino, E. Wang, 2021, Principles of Translational Science in Medicine.

Potency Analysis of Cellular Therapies

F. Marincola, M. Sabatino, E. Wang, 2015 .

Quality assessment of cellular therapies: the emerging role of molecular assays

F. Marincola, M. Sabatino, E. Wang, 2010, The Korean journal of hematology.

Molecular signatures of maturing dendritic cells: implications for testing the quality of dendritic cell therapies

Ping Jin, Francesco M Marincola, Ena Wang, 2010, Journal of Translational Medicine.

Global transcriptional analysis for biomarker discovery and validation in cellular therapies.

Ping Jin, Francesco M Marincola, Marianna Sabatino, 2009, Molecular diagnosis & therapy.

Potency analysis of cellular therapies: the emerging role of molecular assays

E. Wang, D. Stroncek, P. Jin, 2007, Journal of Translational Medicine.

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

Ji Luo, David F. Stroncek, Chi Ma, 2016, Nature.

Immunotherapy biomarkers 2016: overcoming the barriers

J. Berzofsky, B. Seliger, B. Fox, 2017, Journal of Immunotherapy for Cancer.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, A. Hauschild, J. Malvehy, 2016, Journal of Translational Medicine.

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas

S. Steinberg, B. Wood, M. Sabatino, 2016, Clinical Cancer Research.

MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells

Ping Jin, Francesco M Marincola, Ena Wang, 2009, Journal of Translational Medicine.

Melanoma Cell Propagation: Cancer Stem Cell, Clonal Evolution and Interconversion Models of Tumorigenicity

F. Marincola, M. Sabatino, E. Wang, 2012 .

Cancer Stem Cells in Melanoma

F. Marincola, M. Sabatino, E. Wang, 2011 .

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance

D. Stroncek, Hang Gao, P. Jin, 2017, Journal of Translational Medicine.

CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera

D. Stroncek, M. Bettinotti, L. Caruccio, 2004, Journal of Translational Medicine.

Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a

S. Adams, E. Wang, D. Stroncek, 2009, Journal of Translational Medicine.

Investigation of whether the acute hemolysis associated with Rho(D) immune globulin intravenous (human) administration for treatment of immune thrombocytopenic purpura is consistent with the acute hemolytic transfusion reaction model

D. Stroncek, D. Scott, L. Uhl, 2009, Transfusion.

The stable traits of melanoma genetics: an alternate approach to target discovery

F. Marincola, D. Bedognetti, E. Wang, 2012, BMC Genomics.

A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer

S. Steinberg, K. Zoon, D. Stroncek, 2018, Journal of Translational Medicine.

An immunologic portrait of cancer

F. Marincola, D. Bedognetti, E. Wang, 2011, Journal of Translational Medicine.

Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016

J. Taube, P. Ascierto, G. Ciliberto, 2017, Journal of Translational Medicine.

F. Marincola, P. Ascierto, D. Bedognetti, 2014, Journal of Translational Medicine.

Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology

F. Marincola, J. Malek, E. Wang, 2013, The Journal of investigative dermatology.

The stable traits of melanoma genetics: an alternate approach to target discovery

F. Marincola, D. Bedognetti, E. Wang, 2012, BMC Genomics.

Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument

Opal L. Reddy, D. Stroncek, C. Mackall, 2019, Clinical hematology international.

Inflammatory protein profile during systemic high dose interleukin‐2 administration

F. Marincola, G. Hortin, E. Wang, 2006, Proteomics.

Minimal Residual Disease Negative Complete Remissions Following Anti-CD22 Chimeric Antigen Receptor (CAR) in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)

M. Stetler-Stevenson, D. Stroncek, T. Fry, 2016 .

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

Ivan Martin, John Barrett, Donald G Phinney, 2016, Cytotherapy.

Soliciting Strategies for Developing Cell-Based Reference Materials to Advance Mesenchymal Stromal Cell Research and Clinical Translation

Glyn Stacey, Peiman Hematti, Sowmya Viswanathan, 2014 .

Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serum

M. Sabatino, D. Stroncek, P. Robey, 2018, Journal of Translational Medicine.

Benign Ethnic Neutropenia in Individuals of African Descent: Incidence, Granulocyte Mobilization, and Gene Expression Profiling.

J. Everhart, E. Wang, Kayu Chin, 2005 .

Characterization of a new alloantigen (SH) on the human neutrophil Fc gamma receptor IIIb.

P. Bierling, D. Stroncek, P. Fromont, 1997, Blood.

Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis

F. Marincola, E. Wang, D. Stroncek, 2008, Journal of Translational Medicine.

New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer

F. Marincola, J. Heath, S. Rosenberg, 2012, Journal of Translational Medicine.

Infusion of hemolyzed red blood cells within peripheral blood stem cell grafts in patients with and without sickle cell disease.

G. Kato, D. Stroncek, J. Tisdale, 2012, Blood.

Patient‐specific transfusion‐related acute lung injury

D. Stroncek, S. Leitman, H. Klein, 2007, Vox sanguinis.

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

N. Geller, N. Young, P. Scheinberg, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chapter 10 – Human Leukocyte and Granulocyte Antigens and Antibodies: The HLA and HNA Systems

F. Marincola, S. Adams, E. Wang, 2007 .

Neutrophil alloantibodies react with cytoplasmic antigens: a possible cause of false-positive indirect immunofluorescence assays for antibodies to neutrophil cytoplasmic antigens.

D. Stroncek, M. Clay, G. Eiber, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Alloimmune neonatal neutropenia due to an antibody to the neutrophil Fc-gamma receptor III with maternal deficiency of CD16 antigen.

D. Stroncek, R. Shankar, M. Clay, 1991, Blood.

Human neutrophil antigens

D. Stroncek, J. Bux, 2002, Transfusion.

Optimizing a fully automated and closed system process for red blood cell reduction of human bone marrow products.

D. Stroncek, Yihua Cai, P. Jin, 2023, Cytotherapy.

Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation

M. Bishop, D. Stroncek, S. Pavletic, 2014, Transfusion.

Stability of cryopreserved white blood cells (WBCs) prepared for donor WBC infusions

M. Sabatino, D. Stroncek, P. Jin, 2011, Transfusion.

Establishment of a cell processing laboratory to support hematopoietic stem cell transplantation and chimeric antigen receptor (CAR)-T cell therapy.

Opal L. Reddy, D. Stroncek, S. Panch, 2021, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

J. Wingard, D. Stroncek, B. Shaw, 2013, Blood.

Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

E. Wang, D. Stroncek, R. Donahue, 2009, Blood.

Another example of a KEL1 variant red cell phenotype due to a threonine to serine change at position 193 of Kell glycoprotein

S. Adams, D. Stroncek, F. Robbins, 2008, Transfusion.

Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

A. Barrett, D. Stroncek, R. Childs, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preliminary evaluation of a highly automated instrument for the selection of CD34+ cells from mobilized peripheral blood stem cell concentrates

M. Sabatino, Jeffery L. Miller, D. Stroncek, 2016, Transfusion.

Proposed policies and procedures for the establishment of a cord blood bank.

D. Stroncek, J. McCullough, M. Clay, 1994, Blood cells.

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.

J. Wingard, D. Stroncek, J. Liesveld, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Universal platelets: “A” change in dogma

D. Stroncek, 2005 .

[Effect of leukapheresis on gene expression profiles of donor's peripheral blood mononuclear cells].

D. Stroncek, P. Jin, J. W. Shin, 2008, The Korean journal of laboratory medicine.

Lack of relation of granulocyte antibodies (antineutrophil antibodies) to neutropenia in children with human immunodeficiency virus infection.

D. Stroncek, D. Korones, G. Weinberg, 1997, The Pediatric infectious disease journal.

Rapid donor T‐cell engraftment increases the risk of chronic graft‐versus‐host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes

N. Geller, N. Young, D. Stroncek, 2013, American journal of hematology.

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival.

J. Wagner, M. Horowitz, J. Wingard, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NK Cell KIR Ligand Mismatches Influence Engraftment Following Combined Haploidentical and Umbilical Cord Blood (UCB) Transplantation In Patients With Severe Aplastic Anemia (SAA)

D. Stroncek, R. Childs, S. Leitman, 2013 .

Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.

P. Muranski, A. Barrett, N. Hensel, 2017, Cytotherapy.

Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor.

D. Stroncek, D. Korones, M. Gilmore, 1994, The Journal of pediatrics.

Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative

D. Stroncek, J. Reems, M. Fontaine, 2018, Transfusion.

Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28–29 2017, Doha, Qatar)

Peter R Parham, F. Marincola, R. Fuleihan, 2018, Journal of Translational Medicine.

Identification of the HNA-3a antigen.

D. Stroncek, C. Silliman, 2010, Blood.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

S. Steinberg, M. Sabatino, B. Levine, 2013, Blood.

Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.

P. Muranski, K. Keyvanfar, A. Barrett, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Granulocyte antigens and antibody detection.

D. Stroncek, 2004, Vox sanguinis.

ES07.03  Granulocyte antigens and antibody detection

D. Stroncek, 2004 .

Molecular characterization of antigenic polymorphisms (Ond(a) and Mart(a)) of the beta 2 family recognized by human leukocyte alloantisera.

D. Stroncek, C. E. van der Schoot, A. von dem Borne, 1996, Blood.

The use of bioinformatics to identify the genomic structure of the gene that encodes neutrophil antigen NB1, CD177.

A. Olsen, D. Stroncek, M. Bettinotti, 2002, Clinical Immunology.

Chapter 113 – Human Leukocyte Antigen and Human Neutrophil Antigen Systems

F. Marincola, S. Adams, E. Wang, 2018 .

Is it time to standardize granulocyte alloantigen nomenclature?

D. Stroncek, J. Bux, 2002, Transfusion.

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

S. Steinberg, A. Fojo, B. Levine, 2015, Clinical Cancer Research.

Let-7 microRNAs are developmentally regulated in circulating human erythroid cells

F. Marincola, S. Goh, Y. T. Lee, 2009, Journal of Translational Medicine.

Advances in gene therapy for hematologic disease and considerations for transfusion medicine.

Opal L. Reddy, D. Stroncek, B. Savani, 2020, Seminars in hematology.

Analysis of memory T lymphocyte activity following stimulation with overlapping HLA-A*2402, A*0101 and Cw*0402 restricted CMV pp65 peptides

D. Stroncek, M. Provenzano, M. Ghei, 2005, Journal of Translational Medicine.

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers

S. H. van der Burg, F. Marincola, A. Palucka, 2011, Clinical Cancer Research.

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment

Yingdong Zhao, Davide Bedognetti, Francesco M Marincola, 2011, BMC Medical Genomics.

Gene Expression Analysis of Ex Vivo Expanded and Freshly Isolated NK Cells From Cancer Patients

M. Sabatino, D. Stroncek, M. Berg, 2010, Journal of immunotherapy.

Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

Qian Zhang, Francesco M Marincola, Marianna Sabatino, 2009, BMC Genomics.

Evaluation of 3 Clinical Dendritic Cell Maturation Protocols Containing Lipopolysaccharide and Interferon-γ

F. Marincola, D. Stroncek, Jiaqiang Ren, 2009, Journal of immunotherapy.

Gene expression profiling of cutaneous wound healing

F. Marincola, E. Wang, D. Stroncek, 2007, Journal of Translational Medicine.

Journal of Translational Medicine Molecular Signatures Induced by Interleukin-2 on Peripheral Blood Mononuclear Cells and T Cell Subsets

F. Marincola, E. Wang, D. Stroncek, 2022 .

Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms

F. Marincola, E. Wang, D. Stroncek, 2005, Journal of Translational Medicine.

Meeting report from the “ Melanoma Research : a bridge from Naples to the World . Napoli , December 5 th – 6 th 2011 ”

A. Hauschild, K. Flaherty, P. Ascierto, 2012 .

The immunologic aspects of poxvirus oncolytic therapy

F. Marincola, E. Wang, D. Stroncek, 2009, Cancer Immunology, Immunotherapy.

Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome

N. Geller, S. Adams, D. Stroncek, 2021, British journal of haematology.

Mesenchymal stromal cell plasticity and the tumor microenvironment.

D. Stroncek, P. Jin, Shutong Liu, 2017, Emerging topics in life sciences.

Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest

James J. Morrow, F. Marincola, M. Raffeld, 2014, Cancer Immunology Research.

Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy

D. Stroncek, R. Somerville, P. Jin, 2022, Scientific Reports.

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma

S. Rosenberg, P. Youkharibache, D. Stroncek, 2019, Nature Medicine.

Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease

S. Davis, W. Telford, D. Stroncek, 2016, The Journal of Immunology.

Gene therapy simplified.

D. Stroncek, Jiaqiang Ren, 2016, Blood.

Comment on Richter et al , page 2206 Gene therapy simplified-----------------------------------------------------------------------------------------------------Jiaqiang Ren and

D. Stroncek, 2016 .

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL

S. Steinberg, E. Baker, M. Stetler-Stevenson, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Monocyte-derived DC maturation strategies and related pathways: a transcriptional view

F. Marincola, M. Sabatino, A. Krensky, 2011, Cancer Immunology, Immunotherapy.

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"

Yingdong Zhao, Holden Maecker, Sylvia Janetzki, 2008, Journal of Translational Medicine.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013

B. Schilling, F. Marincola, R. Sullivan, 2014, Journal of Translational Medicine.

T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma.

Syed Abbas Ali, Michael Wang, Michael L. Wang, 2016, Blood.

Melanoma and immunotherapy bridge 2015

Andrew J. Park, David C. Smith, A. Hauschild, 2016, Journal of Translational Medicine.

Summit on cell therapy for cancer: The importance of the interaction of multiple disciplines to advance clinical therapy

J. O’Shea, D. Stroncek, C. Melief, 2011, Journal of Translational Medicine.

Summit on Cell Therapy for Cancer Pre-meeting Report Interaction @bullet Innovation @bullet Integration @bullet Exchange @bullet Translation @bullet Leadership Guiding Cancer Immunotherapy from Bench to Bedside Summit on Cell Therapy for Cancer: the Importance of the Interaction of Multiple Discipli

J. O’Shea, D. Stroncek, C. Melief, 2022 .

T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor with a CD28 Costimulatory Moiety Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Michael L. Wang, M. Stetler-Stevenson, D. Stroncek, 2017 .

Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy.

F. Marincola, M. Sabatino, E. Wang, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cryopreserving and deglycerolizing sickle cell trait red blood cell components using an automated cell-processing system

D. Stroncek, K. Byrne, B. J. Bryant, 2008, Immunohematology.

Highlights of the society for immunotherapy of cancer (SITC) 27th annual meeting

F. Marincola, R. Puri, L. Zitvogel, 2013, Journal of Immunotherapy for Cancer.

Spontaneous and treatment-induced cancer rejection in humans

F. Marincola, M. Sabatino, E. Wang, 2008 .

Identification of HLA-A33-restricted CMV pp65 epitopes as common targets for CD8(+) CMV-specific cytotoxic T lymphocytes.

D. Stroncek, M. Bettinotti, Jong-Baeck Lim, 2006, Experimental hematology.

The matrix protein pp65341‐350: a peptide that induces ex vivo stimulation and in vitro expansion of CMV‐specific CD8+ T cells in subjects bearing either HLA‐A*2402 or A*0101 allele

F. Marincola, S. Mocellin, D. Stroncek, 2003, Transfusion.

Removal Of Myeloid Cells From Autologous Leukocytes Used For Chimeric Antigen Receptor (Car) T Cell Manufacturing Improves Final Product Consistency And Yields

M. Sabatino, D. Stroncek, C. Mackall, 2017 .

Advancing Cancer Biotherapy with Proteomics

F. Marincola, B. Martin, D. Stroncek, 2005, Journal of immunotherapy.

Analysis of vaccine-induced T cells in humans with cancer.

F. Marincola, E. Wang, D. Stroncek, 2010, Advances in experimental medicine and biology.

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

C. Croce, L. Fattore, R. Mancini, 2017, Journal of Translational Medicine.

Myeloid cells in peripheral blood mononuclear cell concentrates inhibit the expansion of chimeric antigen receptor T cells.

M. Sabatino, D. Stroncek, C. Mackall, 2016, Cytotherapy.

T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain Induce Remissions in Patients with Relapsed Multiple Myeloma

N. Trinklein, M. Stetler-Stevenson, D. Stroncek, 2019, Blood.

High efficiency closed-system gene transfer using automated spinoculation

D. Stroncek, Yihua Cai, P. Jin, 2021, Journal of Translational Medicine.

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells

M. Sabatino, R. Kaplan, D. Stroncek, 2017, Journal of Translational Medicine.

CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects

F. Marincola, S. Adams, D. Stroncek, 2007, Journal of Translational Medicine.

Comprehensive epitope mapping of the Epstein–Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals

F. Marincola, S. Adams, E. Wang, 2007, Cancer Immunology, Immunotherapy.

Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation

D. Harlan, E. Wang, D. Stroncek, 2007, Journal of Translational Medicine.

Plasma from some cancer patients inhibits adenoviral Ad5f35 vector transduction of dendritic cells.

J. Berzofsky, A. Remaley, Yingdong Zhao, 2018, Cytotherapy.

Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells

M. Sabatino, B. Levine, C. Civin, 2011, Journal of immunotherapy.

Interferon-γ and Tumor Necrosis Factor-α Polarize Bone Marrow Stromal Cells Uniformly to a Th1 Phenotype

F. Marincola, D. Bedognetti, E. Wang, 2016, Scientific Reports.

Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer Patients

J. Berzofsky, M. Sabatino, D. Stroncek, 2017, Clinical Cancer Research.

Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.

Yingdong Zhao, Raj K Puri, Francesco M Marincola, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Treatment of Patients with T Cells Expressing a Fully-Human Anti-BCMA CAR with a Heavy-Chain Antigen-Recognition Domain Caused High Rates of Sustained Complete Responses and Relatively Mild Toxicity

S. Rosenberg, T. Lowe, J. Yang, 2021, Blood.

Deep and Durable Remissions of Relapsed Multiple Myeloma on a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) with a Fully-Human Heavy-Chain-Only Antigen Recognition Domain

S. Rosenberg, J. Yang, M. Stetler-Stevenson, 2020 .

TRF_14832 854..857

D. Stroncek, D. McKenna, A. Mathew, 2019 .

Developments in clinical cell therapy.

S. Heimfeld, M. Sabatino, C. Rooney, 2010, Cytotherapy.

Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.

M. Raffeld, D. Stroncek, T. Fry, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation

M. Sabatino, C. Hourigan, A. Barrett, 2016, Supportive Care in Cancer.

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

M. Sabatino, P. Muranski, A. Barrett, 2018, Blood.

Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor.

F. Marincola, D. Stroncek, J. Tisdale, 2005, Experimental hematology.

Antibodies to granulocytes in patients infected with human immunodeficiency virus.

D. Stroncek, J. Greenspan, H. Hollander, 1992, The Journal of laboratory and clinical medicine.

Effects of storage time and exogenous protease inhibitors on plasma protein levels.

Francesco M Marincola, F. Marincola, D. Stroncek, 2006, American journal of clinical pathology.

Article Status Summary Referee Responses

A. Schechter, D. Stroncek, B. Piknova, 2022 .

Retroviral transduction and expansion of peripheral blood lymphocytes for the treatment of mucopolysaccharidosis type II, Hunter's syndrome

D. Stroncek, A. Hubel, C. Whitley, 1999, Transfusion.

Characterization of HLH-Like Manifestations as a CRS Variant in Patients Receiving CD22 CAR T-Cells.

E. Ruppin, S. Steinberg, N. Taylor, 2021, Blood.

Associations between HLA Class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians

F. Marincola, S. Adams, E. Wang, 2007, Journal of Translational Medicine.

Therapeutic apheresis for babesiosis

D. Stroncek, B. Kloster, E. Perry, 1998, Journal of clinical apheresis.

Increasing oxygen tension improves filtration of sickle trait donor blood

A. Schechter, D. Stroncek, S. Leitman, 2003, British journal of haematology.

Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration

A. Schechter, D. Stroncek, C. Noguchi, 2002, Transfusion.

Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment.

M. Sabatino, D. Stroncek, P. Robey, 2015, Cytotherapy.

Hemolytic anemia and acute renal failure associated with temafloxacin‐dependent antibodies

D. Stroncek, R. Maguire, Eric Gale, 1994, American journal of hematology.

Factors affecting the formation of white particulate matter in red blood cell components

D. Stroncek, M. Horne, K. Byrne, 2005, Transfusion.

National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation.

D. Stroncek, J. Barrett, L. Harvath, 2002, Cytotherapy.

Leukoreduction filtration of whole‐blood units from sickle trait donors: effects of a metered citrate anticoagulant system

D. Stroncek, R. Wesley, M. Bianchi, 2007, Transfusion.

Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model

F. Marincola, E. Wang, D. Stroncek, 2009, Journal of Translational Medicine.

Drug‐induced hemolysis: Cefotetan‐dependent hemolytic anemia mimicking an acute intravascular immune transfusion reaction

D. Stroncek, J. Procter, Judy Johnson, 2000, American journal of hematology.

Remissions of Multiple Myeloma during a First-in-Humans Clinical Trial of T Cells Expressing an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor

Michael L. Wang, M. Stetler-Stevenson, D. Stroncek, 2015 .

Analysis of a high‐throughput HLA antibody screening assay for use with platelet donors

F. Marincola, S. Adams, D. Stroncek, 2008, Transfusion.

Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.

D. Stroncek, B. Savani, S. Panch, 2019, Seminars in hematology.

Transfusion support in patients with hematologic disease: Transfusions in special clinical circumstances.

D. Stroncek, B. Savani, S. Panch, 2020, Seminars in hematology.

Pilot analysis of cytokines levels in stored granulocyte–colony‐stimulating factor–mobilized peripheral blood stem cell concentrates

M. Sabatino, D. Stroncek, K. Byrne, 2010, Transfusion.

Evaluation of gene expression profiles of immature dendritic cells prepared from peripheral blood mononuclear cells

F. Marincola, E. Wang, D. Stroncek, 2008, Transfusion.

Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses

M. Sabatino, Xingmin Feng, J. Melenhorst, 2014, Stem cells.

Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells Produce Complete Responses With Acceptable Toxicity But Without Chronic B-Cell Aplasia In Children With Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL) Even After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

S. Rosenberg, M. Sabatino, M. Stetler-Stevenson, 2013 .

Increasing hemoglobin oxygen saturation levels in sickle trait donor whole blood prevents hemoglobin S polymerization and allows effective white blood cell reduction by filtration

A. Schechter, D. Stroncek, C. Noguchi, 2004, Transfusion.

Is it time to reconsider neutrophil antibody testing of platelet donors?

D. Stroncek, M. Clay, 2011, Transfusion.

Systemic translocation of Staphylococcus drives autoantibody production in HIV disease

A. Alekseyenko, Min Li, Quanzhen Li, 2019, Microbiome.

Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center.

Marianna Sabatino, M. Sabatino, D. Stroncek, 2014, Tissue engineering. Part B, Reviews.

Counter-flow elutriation of clinical peripheral blood mononuclear cell concentrates for the production of dendritic and T cell therapies

M. Sabatino, D. Stroncek, V. Fellowes, 2014, Journal of Translational Medicine.

15 kDa Granulysin versus GM-CSF for monocytes differentiation: analogies and differences at the transcriptome level

F. Marincola, M. Sabatino, E. Wang, 2011, Journal of Translational Medicine.

Global Transcriptional Analysis for Biomarker Discovery and Validation in Cellular Therapies

F. Marincola, M. Sabatino, E. Wang, 2012, Molecular Diagnosis & Therapy.

Comparison of human bone marrow stromal cells cultured in human platelet growth factors and fetal bovine serum

M. Sabatino, D. Stroncek, P. Robey, 2018, Journal of Translational Medicine.

Safety and Response of Incorporating CD19 Chimeric Antigen Receptor T Cell Therapy in Typical Salvage Regimens for Children and Young Adults with Acute Lymphoblastic Leukemia

S. Rosenberg, M. Stetler-Stevenson, D. Stroncek, 2015 .

Evaluation of the gel system for ABO grouping and D typing

D. Stroncek, D F Stroncek, J. Procter, 1999, Transfusion.

The Microarray Signature of Rhesus Macaque CD34+CD123 (IL-3 Receptor)+ Hematopoietic Stem/Progenitor Cells Isolated Following Mobilization with Plerixafor Alone or in Combination with Granulocyte Colony-Stimulating Factor (G-CSF)

D. Stroncek, R. Donahue, M. Metzger, 2011 .

T Cells Expressing a Novel Fully-Human Anti-CD19 Chimeric Antigen Receptor Induce Remissions of Advanced Lymphoma in a First-in-Humans Clinical Trial

S. Pittaluga, M. Bagheri, D. Stroncek, 2016 .

Granulocyte transfusions in children and adults with hematological malignancies: benefits and controversies

S. Rutella, D. Stroncek, P. Filippini, 2015, Journal of Translational Medicine.

Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays

D. Stroncek, P. Jin, S. Highfill, 2023, Cytotherapy.

S. Steinberg, K. Zoon, D. Stroncek, 2018, Journal of translational medicine.

Granulocyte storage and antigen stability

D. Stroncek, J. Procter, H. Chun, 1999, Transfusion.

Practice Patterns for Evaluation, Consent and Care of Related Donors and Recipients At Hematopoietic Stem Cell Transplant Centers in the United States: Is Conflict-of-Interest an Unrecognized Issue?

D. Stroncek, M. Pulsipher, S. Leitman, 2009 .

Detection of antibodies in acid eluates with the gel microcolumn assay

D. Stroncek, J. Procter, K. Byrne, 2002, Transfusion.

Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use

K. Zoon, D. Stroncek, C. Annunziata, 2019, Journal of Translational Medicine.

Inflammatory Protein Profile During Systemic High Dose Interleukin-2 Administration

F. Marincola, G. Hortin, E. Wang, 2005 .

Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation

D. Stroncek, 2004, Vox sanguinis.

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells

M. Sabatino, R. Kaplan, D. Stroncek, 2017, Journal of Translational Medicine.

Gene expression signatures of interleukin-2 in vivo and in vitro and their relation to anticancer therapy.

F. Marincola, E. Wang, D. Stroncek, 2007, Critical Reviews in Immunology.

NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease.

Linhong Li, D. Kuhns, D. Stroncek, 2020, Blood advances.

CD19/22 CAR T-cells in Children and Young Adults with B-ALL: Phase I Results and Development of a Novel Bicistronic CAR.

S. Steinberg, G. Altan-Bonnet, D. Stroncek, 2022, Blood.

Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture

Yingdong Zhao, D. Stroncek, Jinguo Chen, 2019, Journal of Translational Medicine.

Rapid, single-subject genotyping to predict red blood cell antigen expression

S. Adams, D. Stroncek, L. Caruccio, 2008, Immunohematology.

Spontaneous and treatment-induced cancer rejection in humans.

F. Marincola, M. Sabatino, E. Wang, 2008, Expert opinion on biological therapy.

Generation of clinical grade human bone marrow stromal cells for use in bone regeneration.

David F. Stroncek, Marianna Sabatino, Sergei A. Kuznetsov, 2015, Bone.

Making Anti-CD19 CAR-T Cell Therapy Accessible and Affordable: First-in-Human Phase I Clinical Trial Experience from India

D. Stroncek, S. Highfill, P. Tembhare, 2022, Blood.

Future Perspectives in melanoma research. Meeting report from the Research: a to

A. Hauschild, K. Flaherty, P. Ascierto, 2012 .

Future perspectives in melanoma research

F. Marincola, J. Taube, G. Botti, 2016, Journal of Translational Medicine.

Clinic

R. Puri, D. Stroncek, A. Mowat, 1907, The American journal of dental science.

Systemic translocation of Staphylococcus drives autoantibody production in HIV disease

A. Alekseyenko, Min Li, Quanzhen Li, 2019, Microbiome.

Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016

J. Taube, P. Ascierto, G. Ciliberto, 2017, Journal of Translational Medicine.

Analysis of Memory T Lymphocytes Activity Following Stimulation with HLA-A24, A1 and Cw4 Restricted 9- and 10-mer Cytomegalovirus pp65 Overlapping Peptides.

D. Stroncek, M. Provenzano, M. Ghei, 2004 .

Comprehensive Epitope Mapping of the Epstein-Barr Virus Latent Membrane Protein-2 in Ethnically Diverse Populations

F. Marincola, S. Adams, E. Wang, 2005 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL

D. Dimitrov, M. Sabatino, R. Orentas, 2017, Nature Medicine.

Future perspectives in melanoma research

F. Marincola, J. Taube, G. Botti, 2016, Journal of Translational Medicine.

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014

Martin F. Mihm, B. Schilling, F. Marincola, 2013, Journal of Translational Medicine.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

S. Steinberg, M. Sabatino, B. Levine, 2013, Blood.

Type I Cytokines Synergize with Oncogene Inhibition to Induce Tumor Growth Arrest

James J. Morrow, F. Marincola, M. Raffeld, 2014, Cancer Immunology Research.

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”

F. Marincola, J. Taube, G. Botti, 2013, Journal of Translational Medicine.

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.

I. Martin, S. Viswanathan, L. Ortiz, 2016, Cytotherapy.

Plerixafor (AMD3100) and granulocyte colony-stimulating factor (G-CSF) mobilize different CD34+ cell populations based on global gene and microRNA expression signatures.

E. Wang, D. Stroncek, R. Donahue, 2009, Blood.

Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment

Simon C Watkins, T. Denning, D. Stroncek, 2017, Oncoimmunology.

Evaluation of 3 Clinical Dendritic Cell Maturation Protocols Containing Lipopolysaccharide and Interferon-γ

F. Marincola, D. Stroncek, Jiaqiang Ren, 2009, Journal of immunotherapy.

Journal of Translational Medicine Molecular Signatures Induced by Interleukin-2 on Peripheral Blood Mononuclear Cells and T Cell Subsets

F. Marincola, E. Wang, D. Stroncek, 2006 .

Journal of Translational Medicine Gene Expression Profiling of Cutaneous Wound Healing

F. Marincola, E. Wang, D. Stroncek, 2022 .

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

J. Wingard, D. Stroncek, B. Shaw, 2013, Blood.

Cell and gene therapies: moving from research to clinic

R. Puri, D. Stroncek, 2010, Journal of Translational Medicine.

MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells

F. Marincola, E. Wang, D. Stroncek, 2009, Journal of Translational Medicine.

Journal of Translational Medicine Differentiation of Two Types of Mobilized Peripheral Blood Stem Cells by Microrna and Cdna Expression Analysis

F. Marincola, E. Wang, D. Stroncek, 2022 .

Building smart CAR T cell therapies: The path to overcome current challenges.

D. Stroncek, Violena Pietrobon, Markus Maeurer, 2023, Cancer cell.

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

S. Steinberg, A. Fojo, B. Levine, 2015, Clinical Cancer Research.

Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models.

James M. Harris, L. Zon, M. Dovey, 2011, Cell stem cell.

Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy

F. Marincola, M. Sabatino, E. Wang, 2009, BMC Genomics.

Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science.

F. Marincola, D. Stroncek, B. Kotlán, 2009, Immunotherapy.

CD177: A member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera

D. Stroncek, M. Bettinotti, L. Caruccio, 2004, Journal of Translational Medicine.

Potency analysis of cellular therapies: the emerging role of molecular assays

E. Wang, D. Stroncek, P. Jin, 2007, Journal of Translational Medicine.

Journal of Translational Medicine Gene Expression Profiling of Cutaneous Wound Healing

F. Marincola, E. Wang, D. Stroncek, 2022 .

Identification of a KEL7 subtype: implications for genotyping red blood cell Jsa and Jsb antigens

S. Adams, D. Stroncek, F. Robbins, 2006, Transfusion medicine.

KEL6 and KEL7 genotyping with sequence‐specific primers

S. Adams, D. Stroncek, K. Byrne, 2006, Transfusion.

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance

D. Stroncek, Hang Gao, P. Jin, 2017, Journal of Translational Medicine.